Nektar Therapeutics Inc(NKTR)
2.44
Change: -0.06 (▼ -2.35%)
As of Tue 12/20/2022 12:24 PM% Of Value
Growth
Value Per Share
:
:
:
-162.00
-33.36
-11.8400 (as of 19/12/2022)
Fundamentals Data
| Open | 2.65 | Dividend | 127 |
| Close Price | 2.44 | DivYield | 0 % |
| High | 2.7 | Growth | -51.0 M |
| Low | 2.41 | Growth% | -33.36 |
| P/e | 9.744 | Volume | 1.1 M |
| P/b | -0.97 | Market Capital | 444.5 M |
| Highest High | Lowest Low | ||
| 50 Days Moving Average | 3.39 (as of 20/12/2022) | 50 Days Moving Average Percentage | -25.681481481482 (as of 20/12/2022 |
| Industry: Major Pharmaceuticals |
Charts for balance Sheet:
Balance Sheet Table: last 5 years
Note: Numbers are estimated, Exact figures can be found in Annual Reports
| Type | Year1 / 2017 | Year2 / 2018 | Year3 / 2019 | Year4 / 2020 | Current Year / 2021 |
| Revenue | 307.7 M | 1.1 B | 114.6 M | 152.9 M | 101.9 M |
| Cap Spending | -9.6 M | -11.6 M | -26.2 M | -7.2 M | -14.9 M |
| Operating Expenses | 336.8 M | 480.9 M | 533.2 M | 558.5 M | 523.1 M |
| Operating Cash Flow | -59.6 M | 687.9 M | -440.0 M | -425.1 M | -446.1 M |
| Free Cash Flow | -90.0 M | 706.6 M | -354.9 M | -320.5 M | -427.6 M |
| Free Cash Flow Per Share | -0.578 | 4.166 | -2.028 | -1.795 | -2.333 |
| Total liabilities | 245.2 M | 246.9 M | 391.4 M | 150.2 M | 143.1 M |
| Total cash | 4.7 M | 194.9 M | 96.3 M | 198.9 M | 25.2 M |
| ROE% | -1.757 | 0.502 | -0.29 | -0.37 | -0.62 |
| Outstanding Shares | 160.9 M | 174.1 M | 177.5 M | 182.1 M | 186.2 M |
| P/E | -140.715 | 9.744 | -8.385 | -9.301 | -3.904 |
| P/S | 44.217 | 5.563 | 32.237 | 27.033 | 20.07 |
| Revenue USD | 307.7 M | 1.1 B | 114.6 M | 152.9 M | 101.9 M |
| NO REPORTS FOR THIS STOCK |
Latest Searches
| Stock | Close Price | %of value | Date |
|---|